Financhill
Sell
4

CSLLY Quote, Financials, Valuation and Earnings

Last price:
$52.11
Seasonality move :
0.58%
Day range:
$51.85 - $52.28
52-week range:
$50.85 - $89.71
Dividend yield:
2.8%
P/E ratio:
36.28x
P/S ratio:
3.31x
P/B ratio:
4.51x
Volume:
94.5K
Avg. volume:
159.6K
1-year change:
-35.4%
Market cap:
$50.6B
Revenue:
$15.4B
EPS (TTM):
$1.44

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Downside
    No price target exists because of limited analyst coverage.
  • Price Target Upside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, CSL Ltd. has -- downside to fair value with a price target of -- per share.

CSLLY vs. S&P 500

  • Over the past 5 trading days, CSL Ltd. has underperformed the S&P 500 by -3.11% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • CSL Ltd. does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • CSL Ltd. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter CSL Ltd. reported revenues of $8.2B.

Earnings Growth

  • CSL Ltd. has grown year-over-year earnings for 0 quarters straight. In the most recent quarter CSL Ltd. reported earnings per share of $2.07.
Enterprise value:
96.2B
EV / Invested capital:
--
Price / LTM sales:
3.31x
EV / EBIT:
24.90x
EV / Revenue:
6.43x
PEG ratio (5yr expected):
0.57x
EV / Free cash flow:
-337.91x
Price / Operating cash flow:
20.40x
Enterprise value / EBITDA:
19.96x
Gross Profit (TTM):
$7.4B
Return On Assets:
7.11%
Net Income Margin (TTM):
8.93%
Return On Equity:
14.06%
Return On Invested Capital:
8.85%
Operating Margin:
24.07%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Income Statement
Revenue $11.7B $14B $15.1B -- $8.2B
Gross Profit $5.9B $6.8B $7.3B -- $4.3B
Operating Income $2.8B $3.4B $3.8B -- $2B
EBITDA $3.4B $4.3B $4.8B -- $3.2B
Diluted EPS $2.18 $2.58 $2.82 -- $2.07
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Balance Sheet
Current Assets $12.5B $9.6B $10.1B $11.3B --
Total Assets $23.4B $35.4B $37.3B $38.4B --
Current Liabilities $2.5B $4.3B $4.7B $6.1B --
Total Liabilities $9.4B $17.6B $18.1B $17.9B --
Total Equity $14B $17.9B $19.2B $20.5B --
Total Debt -- -- -- -- --
Trailing 12 Months Fiscal Quarters
Period Ending 1996-09-30 1997-09-30 1998-09-30 1997-09-30 1998-09-30
Cash Flow Statement
Cash Flow Operations -- -- -- $398M $303M
Cash From Investing -- -- -- -$169M $282M
Cash From Financing -- -- -- -$237M -$547M
Free Cash Flow -- -- -- -- --
CSLLY
Sector
Market Cap
$50.6B
$25.8M
Price % of 52-Week High
58.09%
50.24%
Dividend Yield
2.8%
0%
Shareholder Yield
3.2%
-1.64%
1-Year Price Total Return
-35.4%
-18.88%
Beta (5-Year)
0.771
0.496
Dividend yield:
2.8%
Annualized payout:
$1.38
Payout ratio:
-42.55%
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $52.56
200-day SMA
Sell
Level $68.78
Bollinger Bands (100)
Sell
Level 55.46 - 65.34
Chaikin Money Flow
Buy
Level 18.6M
20-day SMA
Sell
Level $57.02
Relative Strength Index (RSI14)
Sell
Level 33.09
ADX Line
Sell
Level 23.37
Williams %R
Buy
Level -92.2286
50-day SMA
Sell
Level $58.36
MACD (12, 26)
Sell
Level -2.41
25-day Aroon Oscillator
Sell
Level -36
On Balance Volume
Neutral
Level 5.6M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (4.1297)
Buy
CA Score (Annual)
Level (0.0398)
--
Beneish M-Score (Annual)
Level (--)
Sell
Momentum Score
Level (2)
Buy
Ohlson Score
Level (-2.0661)
Buy
Piotroski F Score (Annual)
Level (9)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (6)

Revenue Forecast

Earnings per Share Forecast

Company Profile

CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. It operates through the following segments: CSL Behring, CSL Seqirus, and CSL Vifor. The CSL Behring segment provides plasma products, gene therapies, and recombinants. The CSL Seqirus segment includes predominantly influenza related products and provides pandemic services to governments. The CSL Vidor segment focuses on the distribution of products in the therapeutic areas of iron deficiency and nephrology. The company was founded on November 2, 1961 and is headquartered in Melbourne, Australia.

Stock Forecast FAQ

In the current month, CSLLY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CSLLY average analyst price target in the past 3 months is --.

  • Where Will CSL Ltd. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that CSL Ltd. share price will drop to -- per share over the next 12 months.

  • What Do Analysts Say About CSL Ltd.?

    Analysts are divided on their view about CSL Ltd. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that CSL Ltd. is a Sell and believe this share price will rise from its current level to --.

  • What Is CSL Ltd.'s Price Target?

    The price target for CSL Ltd. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is CSLLY A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for CSL Ltd. is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of CSLLY?

    You can purchase shares of CSL Ltd. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase CSL Ltd. shares.

  • What Is The CSL Ltd. Share Price Today?

    CSL Ltd. was last trading at $52.11 per share. This represents the most recent stock quote for CSL Ltd.. Yesterday, CSL Ltd. closed at $52.11 per share.

  • How To Buy CSL Ltd. Stock Online?

    In order to purchase CSL Ltd. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Sell
47
Is NVDA Stock a Buy?

Market Cap: $4.3T
P/E Ratio: 36x

Sell
48
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 35x

Sell
40
Is GOOGL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 29x

Alerts

Buy
54
AAOI alert for Feb 28

Applied Optoelectronics, Inc. [AAOI] is up 56.96% over the past day.

Buy
90
BNAI alert for Feb 28

Brand Engagement Network, Inc. [BNAI] is up 36.02% over the past day.

Buy
57
SEZL alert for Feb 28

Sezzle, Inc. [SEZL] is down 13.92% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock